EMVision (ASX:EMV) is an innovative Australian medical device company seeking to deploy world first electromagnetic portable brain scanner products to address significant unmet clinical needs. EMVision is developing portable, non-invasive, cost effective and safe Point-of-Care neuroimaging products to reduce the patient and health economic burden of stroke. Currently under clinical investigation, EMVision’s technology has the potential to quickly determine stroke vs. non stroke events, differentiate between ischemic and haemorrhagic lesions and identify LVOs that may be suitable for endovascular clot retrieval. The 1st Gen cart-based scanner is intended to also support routine monitoring post treatment/intervention, to identify deterioration earlier, at the bedside.